ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 672073 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 672073; 2) Community: the network communities that were significantly associated with the response to NSC 672073; 3) Molecule: the relationships between components within communities and NSC 672073; 4) MDR: the compounds that were significantly associated with the NSC 672073.

NSC Compound Enrichment Correlation
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.00366577979610622 0.24101662
NSC 328410 Camptothecin Derivative 0.00366577979610622 0.15858333
NSC 335995 Null 0.00366577979610622 -0.11452204
NSC 359239 Antibiotic X-14766A 0.00366577979610622 -0.024645425
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.00366577979610622 0.24556664
NSC 641454 3'-O-(Dimethylaminoethylcarbonyl)-(Z)-combretastatin A-4 0.00366577979610622 0.27721017
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.00366577979610627 0.21183851
NSC 693135 Null 0.00366577979610627 0.2221921
NSC 694075 Null 0.00366577979610627 0.14243423
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.00366577979610627 0.071286809
Total:88  Current:13    [First] [Prev] [Next] [Last]